المؤلفون: Balmforth C; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Simpson J; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Shen L; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Lefkowitz M; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey., Rizkala AR; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey., Rouleau JL; Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada., Shi V; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey., Solomon SD; Brigham and Women's Hospital, Boston, Massachusetts., Swedberg K; University of Gothenburg, Gothenburg, Sweden., Zile MR; Medical University of South Carolina and Ralph H. Johnson Veterans Administration Medical Center, Charleston, South Carolina., Packer M; Baylor University Medical Center, Dallas, Texas., McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address: john.mcmurray@glasgow.ac.uk.

المصدر: JACC. Heart failure [JACC Heart Fail] 2019 Jun; Vol. 7 (6), pp. 457-465. Date of Electronic Publication: 2019 May 08.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101598241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-1787 (Electronic) Linking ISSN: 22131779 NLM ISO Abbreviation: JACC Heart Fail Subsets: MEDLINE

مواضيع طبية MeSH: Aminobutyrates/*therapeutic use , Angiotensin Receptor Antagonists/*therapeutic use , Angiotensin-Converting Enzyme Inhibitors/*therapeutic use , Cardiovascular Diseases/*mortality , Enalapril/*therapeutic use , Heart Failure/*drug therapy , Hospitalization/*statistics & numerical data , Tetrazoles/*therapeutic use, Aged ; Biphenyl Compounds ; Cardiomyopathy, Alcoholic/complications ; Cardiomyopathy, Dilated/complications ; Cardiotoxicity/complications ; Cause of Death ; Dangerous Behavior ; Diabetic Cardiomyopathies/complications ; Drug Combinations ; Female ; Heart Failure/etiology ; Heart Failure/physiopathology ; Heart Valve Diseases/complications ; Humans ; Hypertension/complications ; Infections/complications ; Male ; Middle Aged ; Mortality ; Myocardial Ischemia/complications ; Peripartum Period ; Stroke Volume ; Treatment Outcome ; Valsartan ; Virus Diseases/complications

المؤلفون: Dewan P; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Shen L; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Petrie MC; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Abraham WT; Division of Cardiovascular Medicine, Davis Heart and Lung Research Institute, Ohio State University, Columbus, OH, USA., Atif Ali M; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Chen CH; Department of Medicine, National Yang-Ming University School of Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan., Desai AS; Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA., Dickstein K; University of Bergen, Stavanger University Hospital, Stavanger, Norway., Huang J; Department of Cardiology, First Affiliated Hospital with Nanjing Medical University, Nanjing, China., Kiatchoosakun S; Cardiology, Medicine, Khon Kaen University, Khon Kaen, Thailand., Kim KS; Daegu Catholic University Medical Centre, Daegu, South Korea., Køber L; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., Lai WT; Division of Cardiology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan., Liao Y; Institute of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Mogensen UM; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., Oh BH; Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea., Packer M; Baylor Heart and Vascular Institute, Baylor University Medical Centre, Dallas, TX, USA., Rouleau JL; Institut de Cardiologie de Montréal, Université de Montréal, Montréal, Canada., Shi V; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Sibulo AS Jr; St. Luke's Medical Centre, Quezon City, Philippines., Solomon SD; Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA., Sritara P; Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand., Swedberg K; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.; National Heart and Lung Institute, Imperial College, London, UK., Tsutsui H; Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan., Zile MR; Medical University of South Carolina and Ralph H. Johnson Veterans Administration Medical Centre, Charleston, SC, USA., McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.

المصدر: European journal of heart failure [Eur J Heart Fail] 2019 May; Vol. 21 (5), pp. 577-587. Date of Electronic Publication: 2018 Dec 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE

مواضيع طبية MeSH: Practice Patterns, Physicians'* , Stroke Volume*, Cardiovascular Diseases/*mortality , Heart Failure/*therapy , Hospitalization/*statistics & numerical data, Adrenergic beta-Antagonists/therapeutic use ; Age Distribution ; Aged ; Angiotensin Receptor Antagonists/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Asia/epidemiology ; Asia, Southeastern/epidemiology ; Asia, Western/epidemiology ; Cardiac Resynchronization Therapy Devices ; Cardiotonic Agents/therapeutic use ; Digoxin/therapeutic use ; Disease Management ; Diuretics/therapeutic use ; Europe/epidemiology ; Europe, Eastern/epidemiology ; Asia, Eastern/epidemiology ; Female ; Heart Failure/epidemiology ; Heart Failure/physiopathology ; Heart-Assist Devices ; Humans ; Latin America/epidemiology ; Male ; Middle Aged ; Mineralocorticoid Receptor Antagonists/therapeutic use ; North America/epidemiology ; Pacemaker, Artificial ; Treatment Outcome

المؤلفون: Selvaraj, S., Claggett, B., Pozzi, A., McMurray, J. J. V., Jhund, P. S., Packer, M., Desai, A. S., Lewis, E. F., Vaduganathan, M., Lefkowitz, M. P., Rouleau, J. L., Shi, V. C., Zile, M. R., Swedberg, Karl, 1944, Solomon, S. D.

المصدر: Circulation. 140(17):1369-1379

مصطلحات موضوعية: Cardiac and Cardiovascular Systems, Kardiologi, congestion, congestive heart failure, physical exam, sacubitril, valsartan, peptide-guided therapy, high-risk, hospitalization, hemodynamics, signs, care, mortality, enalapril, symptoms, survival, Cardiovascular System & Cardiology

URL الوصول: https://gup.ub.gu.se/publication/285341

المؤلفون: Vardeny, O., Claggett, B., Kachadourian, J., Desai, A. S., Packer, M., Rouleau, J., Zile, M. R., Swedberg, Karl, 1944, Lefkowitz, M., Shi, V., McMurray, J. J. V., Solomon, S. D.

المصدر: European Journal of Heart Failure. 21(3):337-341

مصطلحات موضوعية: Cardiac and Cardiovascular Systems, Kardiologi, Diuretics, Randomized clinical trial, Heart failure with reduced ejection fraction, Sacubitril/valsartan, Enalapril, progressive heart-failure, death, hospitalization, inhibition, neprilysin, mortality, system, Cardiovascular System & Cardiology

URL الوصول: https://gup.ub.gu.se/publication/279673

المؤلفون: Ehteshami-Afshar, S., Mooney, L., Dewan, P., Desai, A. S., Lang, N. N., Lefkowitz, M. P., Petrie, M. C., Rizkala, A. R., Rouleau, J. L., Solomon, S. D., Swedberg, Karl, 1944, Shi, V. C., Zile, M. R., Packer, M., McMurray, J. J. V., Jhund, P. S., Hawkins, N. M.

المصدر: Journal of the American Heart Association. 10(4)

مصطلحات موضوعية: Cardiac and Cardiovascular Systems, Kardiologi, chronic obstructive pulmonary disease, ejection fraction, heart failure, hospitalization, mortality, neprilysin, right ventricle, Cardiovascular System & Cardiology

URL الوصول: https://gup.ub.gu.se/publication/302623

المؤلفون: Desai, A. S., Claggett, B. L., Packer, M., Zile, M. R., Rouleau, J. L., Swedberg, Karl, 1944, Shi, V., Lefkowitz, M., Starling, R., Teerlink, J., McMurray, J. J. V., Solomon, S. D.

المصدر: Journal of the American College of Cardiology. 68(3):242-248

مصطلحات موضوعية: Cardiac and Cardiovascular Systems, Kardiologi, hospitalization, neprilysin, readmission, sacubitril/valsartan, all-cause readmission, medicare beneficiaries, neprilysin inhibition, care, association, population, guidelines, enalapril, statement, mortality, Cardiovascular System & Cardiology

URL الوصول: https://gup.ub.gu.se/publication/239619

المؤلفون: Okumura, N., Jhund, P. S., Gong, J. J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Swedberg, Karl, 1944, Zile, M. R., Solomon, S. D., Packer, M., McMurray, J. J. V.

المصدر: Circulation. 133(23):2254-2262

مصطلحات موضوعية: Cardiac and Cardiovascular Systems, Kardiologi, emergency service, hospital, heart failure, hospitalization, mortality, neprilysin, sacubitril/valsartan, emergency-department, neprilysin inhibition, hospital readmission, subsequent mortality, care, enalapril, inpatient, outcomes, therapy, risk, Cardiovascular System & Cardiology

URL الوصول: https://gup.ub.gu.se/publication/238291

المؤلفون: Vardeny, O., Claggett, B., Udell, J. A., Packer, M., Zile, M., Rouleau, J., Swedberg, Karl, 1944, Desai, A. S., Lefkowitz, M., Shi, V., McMurray, J. J. V., Solomon, S. D.

المصدر: Jacc-Heart Failure. 4(2):152-158

مصطلحات موضوعية: Clinical Medicine, Klinisk medicin, chronic heart failure, clinical trial, influenza vaccination, college-of-cardiology, cardiovascular-disease, myocardial-infarction, association, risk, hospitalization, immunization, metaanalysis, population, prevention, Cardiovascular System & Cardiology

URL الوصول: https://gup.ub.gu.se/publication/233538

المؤلفون: Kristensen, S. L., Preiss, D., Jhund, P. S., Squire, I., Cardoso, J. S., Merkely, B., Martinez, F., Starling, R. C., Desai, A. S., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, Karl, 1944, Zile, M. R., McMurray, J. J. V., Packer, M.

المصدر: Circulation-Heart Failure. 9(1)

مصطلحات موضوعية: Clinical Medicine, Klinisk medicin, clinical trial, diabetes mellitus, heart failure, prognosis, treatment outcome, cardiovascular risk, insulin-resistance, hemoglobin a(1c), glucose, a1c, hospitalization, dysfunction, inhibition, predictor, tolerance, Cardiovascular System & Cardiology

URL الوصول: https://gup.ub.gu.se/publication/232774

المؤلفون: Hendrik Streefkerk, Victor Shi, Wenchun Zhou, Allen Kaplan, Vikas Modgill, Michele Senni

المساهمون: Shi, V, Senni, M, Streefkerk, H, Modgill, V, Zhou, W, Kaplan, A

المصدر: International Journal of Cardiology. 264:118-123

مصطلحات موضوعية: Male, medicine.medical_specialty, Tetrazoles, Angiotensin-Converting Enzyme Inhibitors, 030204 cardiovascular system & hematology, Risk Assessment, Sacubitril, Angiotensin Receptor Antagonists, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Enalapril, Internal medicine, Anti-Allergic Agents, medicine, Humans, Sacubitril/valsartan, cardiovascular diseases, 030212 general & internal medicine, Angioedema, Adverse effect, Heart Failure, Ejection fraction, business.industry, Aminobutyrates, Biphenyl Compounds, Stroke Volume, HFrEF, Middle Aged, medicine.disease, Hospitalization, Drug Combinations, Treatment Outcome, Valsartan, Heart failure, Cardiology, Female, Safety, medicine.symptom, Cardiology and Cardiovascular Medicine, business, Sacubitril, Valsartan, medicine.drug

وصف الملف: STAMPA

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e4b72c5b8b8f757bbf809e79341b3f1
https://doi.org/10.1016/j.ijcard.2018.03.121